Sonic Healthcare Ltd · Valuation
ASX: SHL · Health Care · Diagnostics & Research
Fair value estimates vs price
A$ per share · models updated 2 Aug 2026
10.5% above fair value A$19.79, the median of our 3 model estimates.
Different models answer different questions. A wide spread between them usually means the market is pricing growth or risk that historical figures don't capture. Estimates are recomputed as new results and prices land.
Discounted cash flow
A$25.02Projects the company's free cash flow forward and discounts it back to today, the most fundamental measure of what a business is worth.
EPS growth model
A$15.56Projects earnings per share forward at the historical growth rate, then discounts back to a present value.
P/E multiple
A$19.79Applies the historical median price-to-earnings ratio to current earnings per share.
Trailing P/E history
Monthly price ÷ trailing diluted EPS · extremes above 100 excluded from stats
Per-share fundamentals
The inputs behind the models
| FY | EPS | Book value / sh | Free cash flow |
|---|---|---|---|
| 2025 | $1.07 | $17.60 | $960.5M |
| 2024 | $1.07 | $16.93 | $600.9M |
| 2023 | $1.45 | $16.77 | $1.1B |
| 2022 | $3.03 | $15.38 | $1.9B |
| 2021 | $2.73 | $13.51 | $1.8B |
| 2020 | $1.11 | $11.87 | $1.1B |
| 2019 | $1.22 | $12.20 | $565.7M |
| 2018 | $1.12 | $10.11 | $542.3M |
| 2017 | $1.02 | $9.37 | $399.5M |
| 2016 | $1.09 | $9.04 | $385.3M |
Looking for value across the whole market? The ASX screener lists every covered company trading below our fair-value models, refreshed each trading day.
Data is general information only, not financial advice. Figures are as reported in company filings (some ASX companies report in USD); share prices are AUD.